|

Letrozole-matching placebo Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 3: 1

Top Sponsors

  • Olema Pharmaceuticals, Inc.1

Indications

  • ER-positive Breast Cancer1
  • HER2-Negative Breast Carcinoma1
  • Locally Advanced Breast Cancer1
  • Metastatic Breast Cancer1
  • Breast Cancer1

Hot Springs, Arkansas1 trial

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.